Effect of immunisation with cancer procoagulant on the growth of Walker 256 carcinosarcoma cells in rats

M. Kamocka, K. Kaplinska, W. P. Mielicki

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The effect of preimmunisation with cancer procoagulant (CP) on the growth of Walker 256 carcinosarcoma cells in Wistar Lew/Han/IMP rats in vivo has been analysed. One group of rats was immunised with CP purified from human amnion-chorion membranes. The rest of the animals (control groups) were injected with 0.9% NaCl in Freund's adjuvant or were not immunised at all. When the presence of polyclonal anti-CP antibody was detected in CP-immunised rats' serum, all (CP-immunised and control) animals were injected i.p. with 4.8×105 Walker 256 cells per rat. After 5 days ascitic fluid was collected and viable cells were counted. The complete lack of viable Walker 256 carcinosarcoma cells in 24% of the CP-immunised rats was observed. However, the viable neoplastic cells were present in all control (NaCl-injected and non-immunised) animals. It seems possible that CP plays an important role in tumour progression, so immunisation with CP can reduce the risk of development of malignant disease.

Original languageEnglish (US)
Pages (from-to)119-123
Number of pages5
JournalClinical and Experimental Medicine
Volume6
Issue number3
DOIs
StatePublished - Oct 1 2006

Fingerprint

cancer procoagulant
Walker Carcinoma 256
Immunization
Rats
Growth
Animals
Chorion
Inosine Monophosphate
Amnion
Freund's Adjuvant
Ascitic Fluid

Keywords

  • Cancer growth inhibition
  • Cancer procoagulant
  • Immunisation
  • Walker 256

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Effect of immunisation with cancer procoagulant on the growth of Walker 256 carcinosarcoma cells in rats. / Kamocka, M.; Kaplinska, K.; Mielicki, W. P.

In: Clinical and Experimental Medicine, Vol. 6, No. 3, 01.10.2006, p. 119-123.

Research output: Contribution to journalArticle

@article{cb255b04ac4b485e8469c84b8e764edd,
title = "Effect of immunisation with cancer procoagulant on the growth of Walker 256 carcinosarcoma cells in rats",
abstract = "The effect of preimmunisation with cancer procoagulant (CP) on the growth of Walker 256 carcinosarcoma cells in Wistar Lew/Han/IMP rats in vivo has been analysed. One group of rats was immunised with CP purified from human amnion-chorion membranes. The rest of the animals (control groups) were injected with 0.9{\%} NaCl in Freund's adjuvant or were not immunised at all. When the presence of polyclonal anti-CP antibody was detected in CP-immunised rats' serum, all (CP-immunised and control) animals were injected i.p. with 4.8×105 Walker 256 cells per rat. After 5 days ascitic fluid was collected and viable cells were counted. The complete lack of viable Walker 256 carcinosarcoma cells in 24{\%} of the CP-immunised rats was observed. However, the viable neoplastic cells were present in all control (NaCl-injected and non-immunised) animals. It seems possible that CP plays an important role in tumour progression, so immunisation with CP can reduce the risk of development of malignant disease.",
keywords = "Cancer growth inhibition, Cancer procoagulant, Immunisation, Walker 256",
author = "M. Kamocka and K. Kaplinska and Mielicki, {W. P.}",
year = "2006",
month = "10",
day = "1",
doi = "10.1007/s10238-006-0106-7",
language = "English (US)",
volume = "6",
pages = "119--123",
journal = "Clinical and Experimental Medicine",
issn = "1591-8890",
number = "3",

}

TY - JOUR

T1 - Effect of immunisation with cancer procoagulant on the growth of Walker 256 carcinosarcoma cells in rats

AU - Kamocka, M.

AU - Kaplinska, K.

AU - Mielicki, W. P.

PY - 2006/10/1

Y1 - 2006/10/1

N2 - The effect of preimmunisation with cancer procoagulant (CP) on the growth of Walker 256 carcinosarcoma cells in Wistar Lew/Han/IMP rats in vivo has been analysed. One group of rats was immunised with CP purified from human amnion-chorion membranes. The rest of the animals (control groups) were injected with 0.9% NaCl in Freund's adjuvant or were not immunised at all. When the presence of polyclonal anti-CP antibody was detected in CP-immunised rats' serum, all (CP-immunised and control) animals were injected i.p. with 4.8×105 Walker 256 cells per rat. After 5 days ascitic fluid was collected and viable cells were counted. The complete lack of viable Walker 256 carcinosarcoma cells in 24% of the CP-immunised rats was observed. However, the viable neoplastic cells were present in all control (NaCl-injected and non-immunised) animals. It seems possible that CP plays an important role in tumour progression, so immunisation with CP can reduce the risk of development of malignant disease.

AB - The effect of preimmunisation with cancer procoagulant (CP) on the growth of Walker 256 carcinosarcoma cells in Wistar Lew/Han/IMP rats in vivo has been analysed. One group of rats was immunised with CP purified from human amnion-chorion membranes. The rest of the animals (control groups) were injected with 0.9% NaCl in Freund's adjuvant or were not immunised at all. When the presence of polyclonal anti-CP antibody was detected in CP-immunised rats' serum, all (CP-immunised and control) animals were injected i.p. with 4.8×105 Walker 256 cells per rat. After 5 days ascitic fluid was collected and viable cells were counted. The complete lack of viable Walker 256 carcinosarcoma cells in 24% of the CP-immunised rats was observed. However, the viable neoplastic cells were present in all control (NaCl-injected and non-immunised) animals. It seems possible that CP plays an important role in tumour progression, so immunisation with CP can reduce the risk of development of malignant disease.

KW - Cancer growth inhibition

KW - Cancer procoagulant

KW - Immunisation

KW - Walker 256

UR - http://www.scopus.com/inward/record.url?scp=33750291967&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750291967&partnerID=8YFLogxK

U2 - 10.1007/s10238-006-0106-7

DO - 10.1007/s10238-006-0106-7

M3 - Article

C2 - 17061060

AN - SCOPUS:33750291967

VL - 6

SP - 119

EP - 123

JO - Clinical and Experimental Medicine

JF - Clinical and Experimental Medicine

SN - 1591-8890

IS - 3

ER -